NCT05184400Recruiting
Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
Identification of New Biomarkers for Patients With Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) - do They Provide New Information Regarding Diagnosis, Treatment Efficacy, Side Effects, or Prognosis?
Source: ClinicalTrials.gov · Last updated 11 Jan 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
No validated biomarkers exist that can identify patients with biliary tract cancer at an early stage or predict treatment outcomes. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 21 Oct 2021
- Start date
- 1 Jan 2015
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- Herlev and Gentofte Hospital
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT05184400
What you commit to
- Study type: Observational
- Planned participants: 500
- From 1 Jan 2015 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- Histological or cytological diagnosis of BTC
- Patients referred for treatment of BTC
- Signed informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Herlev & Gentofte Hospital Coordinator of this site? Confirm its status | Herlev | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.